{"Q": 1, "answer": "no", "rationale": "The segment mentions trial focus but does not contain an intensifier or comparative modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_20876", "batch_size": 200, "batch_pos": 101, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment is a neutral description of trial focus.", "method": "llm_batch", "batch_id": "batch_2_6304", "batch_size": 200, "batch_pos": 67, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "'would likely focus' is not a moderate verb from the approved list.", "method": "llm_batch", "batch_id": "batch_3_1476", "batch_size": 200, "batch_pos": 196, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_21272", "batch_size": 200, "batch_pos": 188, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "Reports focus of trial without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_20912", "batch_size": 200, "batch_pos": 185, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser + scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_15352", "batch_size": 200, "batch_pos": 144, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation about the threat.", "method": "llm_batch", "batch_id": "batch_7_18664", "batch_size": 200, "batch_pos": 132, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "The segment states 'trial would likely focus on safety and immune response', describing the focus of a trial (part of development capability) without explicit calming keywords.", "method": "llm_batch", "batch_id": "batch_8_21488", "batch_size": 200, "batch_pos": 134, "statement_text": "The late-stage trial would likely focus on safety and immune response.", "article_id": 1745}
